AWARD PURSUANT TO ARTICLE 76, PARAGRAPH 2, LETTER B) OF THE DRUG FABHALTA*56CPS 200M (ACTIVE INGREDIENT IPTACOPAN)

This tender, managed by ASL Roma 2, pertains to the procurement of the pharmaceutical product FABHALTA, specifically in its 56-capsule formulation with a 200mg dosage. The active ingredient is Iptacopan. This is a supply contract for medicinal products, classified under 'Medicinali vari' (various medicines). The procurement followed a single-stage other procedure, as per Article 76, paragraph 2, letter b) of the relevant Italian legislation. The estimated value for this acquisition was EUR 493,994.41. The contract was awarded to NOVARTIS FARMA SPA at the full estimated value of EUR 493,994.41. The procurement was conducted in Rome, Italy. This award highlights ASL Roma 2's commitment to ensuring the availability of specific, potentially advanced, medications for its patient population. The use of the specified legal article suggests a direct award or a specific justification for the procurement method chosen.

This is a supplies contract in the general supplies sector, with a focus on General Supplies. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 493,994.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.